The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ
2007

Evaluating the Diabetes Treatment Satisfaction Questionnaire Change Version (DTSQc)

Sample size: 351 publication Evidence: high

Author Information

Author(s): Clare Bradley, Rosalind Plowright, John Stewart, John Valentine, Elke Witthaus

Primary Institution: Royal Holloway, University of London

Hypothesis

The DTSQc would be more responsive to treatment change particularly when respondents had scored at or near ceiling on the DTSQs at baseline.

Conclusion

The DTSQc, used in conjunction with the DTSQs, overcomes the problem of ceiling effects and provides a means for new treatments to show greater value than is possible with the DTSQs alone.

Supporting Evidence

  • The DTSQc detected more improvement in Treatment Satisfaction than the DTSQs.
  • Significant Treatment effects favoring insulin glargine were found.
  • The DTSQc showed more benefits in the type 1 trial.
  • Patients with baseline scores at ceiling showed greater increases in satisfaction with the DTSQc.

Takeaway

This study shows that a new questionnaire can help people better express their satisfaction with diabetes treatment, especially if they were already very satisfied before.

Methodology

Two multinational, open-label, randomized-controlled trials compared the DTSQs and DTSQc in patients with type 1 and type 2 diabetes.

Limitations

The study's findings may not be generalizable to populations outside of the trial settings.

Participant Demographics

198 patients with type 1 diabetes and 153 patients with type 2 diabetes, including both English- and German-speaking individuals.

Statistical Information

P-Value

p < 0.001

Statistical Significance

p < 0.001

Digital Object Identifier (DOI)

10.1186/1477-7525-5-57

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication